TABLE OF CONTENTS Xlll 



nation of spinal fluid, 256; Diagnosis, 257; Diplococcus catarrhalis, 257; 

 Diplococcus pneumonias, 257; Occurrence, 257; Morphology, 258; Cultures, 

 258; Pneumonia, 259; Toxins, 259; Immunity, 260; Streptococcus viridans, 

 260 ; Streptococcus mucosus, 260 ; Streptococcus pyogenes, 260 ; Occurrence, 

 261; Cultures, 261; Animal inoculation, 262; Surgical infections, 263; Erysip- 

 elas, 263; Puerperal fever, 263; Immunity, 264; Streptococcus lacticus, 264 ; 

 Staphylococcus aureus, 264; Occurrence, 264. Morphology, 264; Cultures, 

 265; Toxins, 265; Animal inoculation, 266; Infection of man, 266; Immunity, 

 266; Vaccine therapy, 266; Staphylococcus alb us, 267; Micrococcus tetra- 

 genus, 267; Sarcina ventriculi, 267; Sarcina aurantiaca, 267; Micrococcus 

 agilis, 267. 



CHAPTER XVII. B ACTERIACE^E : THE SPOROGENIC AEROBES. 



Bacillus mycoides, 268 ; Bacillus vulgatus, 268 ; Bacillus subtilis, 269 ; Parasitism 

 269; Bacillus anthracis, 270; Occurrence, 270; Morphology, 271; Resistance 

 272; Anthrax, 272; Human anthrax, 273; Immunity, 273; Seium, 274. 



CHAPTER XVIII. BACTERIACE.E: THE SPOROGENIC ANAEROBES. 



Group characters and habitat, 275 ; Bacillus endematis, 275 ; Putrefactive prop- 

 erties, 276; Malignant edema, 276; Bacillus feseri, 276; Bacillus welchii, 

 276; Occurrence, 276; Characters, 277; Emphysematous gangrene, 277; Bac- 

 illus tetani, 278; Occurrence, 278; Morphology, 278; Cultures, 279; Toxin, 

 279; Tetanus, 280; Immunity, 281; Antitoxin, 281; Standard unit, 282; Pro- 

 phylaxis and treatment, 283; Bacillus botulinus, 283 ; Botulin, 284; Immune 

 serum, 284; Botulism, 284. 



CHAPTER XIX. BACTERIACE^E: THE BACILLUS or DIPHTHERIA AND 



OTHER SPECIFIC BACILLI PARASITIC ON SUPERFICIAL Mucous 



MEMBRANES. 



Bacillus diphtherias, 285; Occurrence, 285; Culture, 285; Toxin, 288; Diphtheria, 

 289; Bacteriological diagnosis, 290; Transmission of the disease, 292; Immu- 

 nity, 292; Antitoxin, 293; Standard unit of antitoxin, 294; Prophylactic and 

 therapeutic use of antitoxic serum, 295; Untoward effects, 295; Bacillus 

 xerosis, 295; Bacillus hoffmanni, 296; Morax-Axenfeld bacillus, 296; Koch- 

 Weeks bacillus, 296 ; Bacillus pertussis, 296 ; Bacillus influenzas, 297 ; Bac- 

 illus chancri, 298. 



CHAPTER XX. BACTERIACE.E: THE TUBERCLE BACILLUS AND OTHER 

 ACID-PROOF BACTERIA. 



Bacillus tuberculosis, 299; Human type, 300; Occurrence, 300; Morphology, 300; 

 Cultures, 301; Chemical composition, 302; Toxins, 303; Resistance, 304; Tuber- 



